NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$1.85
+0.01 (+0.54%)
Open$1.84
Previous Close$1.84
Day High$1.91
Day Low$1.79
52W High$3.84
52W Low$1.58
Volume—
Avg Volume731.1K
Market Cap58.96M
P/E Ratio—
EPS$-2.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,050.3% upside
Current
$1.85
$1.85
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.55M | 19.28M | 24.16M |
| Net Income | 2.70M | 1.92M | 2.84M |
| Profit Margin | 12.5% | 10.0% | 11.8% |
| EBITDA | 4.73M | 4.55M | 5.86M |
| Free Cash Flow | 2.93M | 1.59M | 2.98M |
| Rev Growth | +2.0% | +3.7% | +21.2% |
| Debt/Equity | 0.67 | 0.51 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |